NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Index- P/E- EPS (ttm)-0.03 Insider Own13.33% Shs Outstand34.06M Perf Week-3.74%
Market Cap35.20M Forward P/E- EPS next Y-0.14 Insider Trans0.97% Shs Float29.53M Perf Month-41.48%
Income-0.77M PEG- EPS next Q-0.04 Inst Own24.23% Short Float1.67% Perf Quarter-50.95%
Sales101.49M P/S0.35 EPS this Y-477.78% Inst Trans-15.63% Short Ratio1.84 Perf Half Y-70.06%
Book/sh0.96 P/B1.08 EPS next Y17.31% ROA-1.38% Short Interest0.49M Perf Year-30.87%
Cash/sh0.63 P/C1.63 EPS next 5Y-18.56% ROE-2.86% 52W Range0.86 - 5.15 Perf YTD-49.51%
Dividend Est.- P/FCF11.03 EPS past 5Y66.71% ROI-1.76% 52W High-80.00% Beta1.62
Dividend TTM- Quick Ratio2.22 Sales past 5Y10.96% Gross Margin17.23% 52W Low19.24% ATR (14)0.10
Dividend Ex-Date- Current Ratio2.63 EPS Y/Y TTM93.09% Oper. Margin0.60% RSI (14)32.46 Volatility5.74% 9.17%
Employees244 Debt/Eq0.42 Sales Y/Y TTM21.38% Profit Margin-0.76% Recom1.00 Target Price4.33
Option/ShortYes / Yes LT Debt/Eq0.34 EPS Q/Q56.44% Payout- Rel Volume0.27 Prev Close1.03
Sales Surprise4.95% EPS Surprise-706.06% Sales Q/Q11.64% EarningsMar 20 BMO Avg Volume268.03K Price1.03
SMA20-6.73% SMA50-30.06% SMA200-57.05% Trades Volume73,051 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-14-24Initiated Rodman & Renshaw Buy $5
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Apr-14-25 06:00AM
Mar-21-25 07:08AM
03:02AM
Mar-20-25 11:44PM
09:37AM
09:36AM Loading…
09:36AM
07:10AM
06:18AM
06:00AM
Mar-19-25 06:00PM
Mar-11-25 06:00AM
Feb-27-25 06:00AM
Feb-20-25 06:00AM
Feb-04-25 06:00AM
Dec-17-24 07:51AM
06:00AM Loading…
06:00AM
Dec-13-24 03:48PM
12:11PM
Dec-12-24 06:00AM
Dec-05-24 06:00AM
Nov-19-24 06:00AM
Nov-13-24 02:06AM
Nov-12-24 10:01PM
07:10AM
06:12AM
06:00AM
Nov-11-24 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
06:00AM Loading…
Oct-14-24 06:00AM
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
Aug-08-24 07:15AM
06:13AM
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
Jul-11-24 06:00AM
May-30-24 06:00AM
May-15-24 08:19AM
03:01AM
12:37AM
May-14-24 10:54AM
07:15AM
06:11AM
06:00AM
Apr-17-24 06:00AM
Apr-16-24 06:00AM
Apr-04-24 06:00AM
Mar-26-24 06:15PM
Mar-25-24 06:00AM
Mar-22-24 09:52AM
Mar-21-24 09:39PM
10:53AM
07:10AM
06:18AM
06:00AM
Mar-11-24 06:15PM
Mar-05-24 06:00PM
Feb-27-24 06:00PM
Feb-20-24 06:00PM
Feb-14-24 06:00PM
Feb-08-24 06:00AM
Jan-08-24 07:30AM
Nov-15-23 01:29PM
Nov-14-23 10:36PM
07:15AM
06:06AM
06:00AM
Nov-07-23 06:00PM
Oct-26-23 06:00PM
Oct-20-23 06:15PM
Oct-18-23 06:00AM
Oct-17-23 06:00AM
Oct-16-23 06:00AM
Oct-13-23 06:15PM
Oct-03-23 06:15PM
06:00AM
Sep-28-23 06:00AM
Sep-27-23 06:15PM
Sep-21-23 06:15PM
06:30AM
Sep-18-23 11:37AM
Sep-07-23 06:00AM
Aug-15-23 12:29PM
Aug-14-23 10:53PM
06:08AM
06:00AM
Aug-11-23 10:28AM
Aug-10-23 10:00AM
Aug-09-23 06:00AM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Irrevocable Larson Family Inve10% OwnerApr 10 '25Buy1.0757,00061,0363,527,000Apr 15 02:02 PM
Irrevocable Larson Family Inve10% OwnerApr 11 '25Buy1.0830,50032,9823,557,500Apr 15 02:02 PM
Strobeck MarkPresident and CEOApr 01 '25Sale1.086,9267,480124,678Apr 02 06:06 PM
Neri JesseSVP, FINANCE AND CFOApr 01 '25Sale1.1088697530,000Apr 02 06:05 PM
Chole TimothySVP, Chief Commercial OfficerApr 01 '25Sale1.082,8683,09746,035Apr 02 06:03 PM
Strobeck MarkOfficerApr 01 '25Proposed Sale1.056,9267,263Apr 01 01:49 PM
Chole TimothyOfficerApr 01 '25Proposed Sale1.052,8683,000Apr 01 01:43 PM
Neri JesseOfficerApr 01 '25Proposed Sale1.06886939Apr 01 01:18 PM
Chole TimothySVP, Chief Commercial OfficerJan 02 '25Sale2.051,0012,05254,170Jan 06 04:44 PM
Strobeck MarkPresident and CEOJan 02 '25Sale2.062,1634,445145,038Jan 06 04:43 PM
Strobeck MarkOfficerJan 02 '25Proposed Sale2.062,1634,445Jan 02 03:18 PM
Chole TimothyOfficerJan 02 '25Proposed Sale2.011,0012,015Jan 02 12:40 PM
RAVICH MARK HDirectorNov 15 '24Sale2.3219,99146,3790Nov 19 04:21 PM
RAVICH MARK HDirectorNov 15 '24Sale2.4010,00024,000121,429Nov 19 04:21 PM
Chole TimothySVP, Chief Commercial OfficerOct 01 '24Sale3.691,0013,68955,171Oct 02 09:55 PM
Strobeck MarkPresident and CEOOct 01 '24Sale3.692,1637,971147,201Oct 02 09:54 PM
Strobeck MarkOfficerOct 01 '24Proposed Sale3.652,1637,900Oct 01 02:05 PM
Chole TimothyOfficerOct 01 '24Proposed Sale3.601,0013,600Oct 01 01:36 PM